Cargando…
A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trial
BACKGROUND: Malignant pleural mesothelioma is an incurable cancer caused by exposure to asbestos. The United Kingdom has the highest death rate from mesothelioma in the world and this figure is increasing. Median survival is 8 to 12 months, and most patients have symptoms at diagnosis. The fittest p...
Autores principales: | Gunatilake, Samal, Brims, Fraser JH, Fogg, Carole, Lawrie, Iain, Maskell, Nick, Forbes, Karen, Rahman, Najib, Morris, Steve, Ogollah, Reuben, Gerry, Stephen, Peake, Mick, Darlison, Liz, Chauhan, Anoop J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180732/ https://www.ncbi.nlm.nih.gov/pubmed/25238873 http://dx.doi.org/10.1186/1745-6215-15-367 |
Ejemplares similares
-
Temperature-controlled laminar airflow in severe asthma for exacerbation reduction (The LASER Trial): study protocol for a randomised controlled trial
por: Storrar, Will, et al.
Publicado: (2016) -
Promoting Independence in Dementia (PRIDE): protocol for a feasibility randomised controlled trial
por: Shafayat, Aisha, et al.
Publicado: (2019) -
Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial
por: Muers, Martin F, et al.
Publicado: (2008) -
Change in physical activity level and clinical outcomes in older adults with knee pain: a secondary analysis from a randomised controlled trial
por: Quicke, Jonathan G., et al.
Publicado: (2018) -
TANDEM TRIAL: a factorial randomised controlled trial of dose and review schedule of bevacizumab (Avastin) for neovascular macular degeneration in the East Midlands
por: Foss, Alexander, et al.
Publicado: (2020)